Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
229 participants
OBSERVATIONAL
2021-09-23
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of PRYSHM for LGBTQIA2S+ Youth
NCT05521906
Prevalence of Medical Care in an Emergency Structure of the Women Victims of Violence Within the Couple
NCT05537415
Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions
NCT01326195
Adult Sexual Risk Behavior Among Women With a History of Childhood Sexual Abuse
NCT00653575
Suicide Prevention for Sexual and Gender Minority Youth (Randomized Controlled Trial)
NCT05669976
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV-negative SwissPrePared participants who are active Online Dating App (ODA) users
to develop and validate a scale measuring problematic online dating app (ODA) use in sexual minorities
Qualitative part: scale development and validation with testing in 3 different participant samples, i.e. preliminary testing (n=10), pilot testing (n=30-60), validation (n=300).
Quantitative part: longitudinal part conducted in the validation sample of the qualitative study part (n=300) with the aim to evaluate the association of scores in the problematic ODA use scale with sexual health and mental health outcomes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
to develop and validate a scale measuring problematic online dating app (ODA) use in sexual minorities
Qualitative part: scale development and validation with testing in 3 different participant samples, i.e. preliminary testing (n=10), pilot testing (n=30-60), validation (n=300).
Quantitative part: longitudinal part conducted in the validation sample of the qualitative study part (n=300) with the aim to evaluate the association of scores in the problematic ODA use scale with sexual health and mental health outcomes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participating in the SwissPrEPared study at center Checkpoint Zurich
* German speaking
Exclusion Criteria
For Inclusion/Exclusion at the SwissPrEPared study see: NCT03893188 at clinicaltrials.gov
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital of Psychiatry Zurich
UNKNOWN
Center for Forensic Hair Analysis, Zurich
UNKNOWN
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Epidemiology, Biostatistics and Prevention Institute
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10001C_192814
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2020-01545
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.